CCA
Checchi Capital Advisers Portfolio holdings
AUM
$1.43B
This Quarter Return
-0.22%
1 Year Return
+13.5%
3 Year Return
+50.97%
5 Year Return
+65.6%
10 Year Return
+122.13%
AUM
$308M
AUM Growth
+$308M
(+4.6%)
Cap. Flow
+$16.1M
Cap. Flow
% of AUM
5.22%
Top 10 Holdings %
Top 10 Hldgs %
26.87%
Holding
381
New
29
Increased
208
Reduced
118
Closed
18
Top Buys
| 1 |
iShares MSCI South Korea ETF
EWY
|
$1.98M |
| 2 |
iShares MSCI India ETF
INDA
|
$1.89M |
| 3 |
SPDR Bloomberg Barclays International Treasury Bond ETF
BWX
|
$1.41M |
| 4 |
Ionis Pharmaceuticals
IONS
|
$1.32M |
| 5 |
iShares MSCI Taiwan ETF
EWT
|
$1.22M |
Top Sells
| 1 |
Vanguard Mega Cap Growth ETF
MGK
|
$564K |
| 2 |
iShares MBS ETF
MBB
|
$387K |
| 3 |
Vanguard Growth ETF
VUG
|
$374K |
| 4 |
LO
LORILLARD INC COM STK
LO
|
$372K |
| 5 |
Vanguard Mid-Cap Growth ETF
VOT
|
$347K |
Sector Composition
| 1 | Healthcare | 10.02% |
| 2 | Technology | 9.29% |
| 3 | Financials | 8.43% |
| 4 | Consumer Staples | 5.59% |
| 5 | Communication Services | 4.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Gilead Sciences
GILD
$140B
| $1.55M | 0.41% |
13,202
-884
| -6% | -$104K |
|
52
Novartis
NVS
$248B
| $1.52M | 0.4% |
17,294
+1,974
| +13% | +$174K |
|
53
Philip Morris
PM
$254B
| $1.52M | 0.4% |
18,905
-440
| -2% | -$35.3K |
|
54
iShares Core MSCI Emerging Markets ETF
IEMG
$102B
| $1.4M | 0.37% |
29,208
-2,104
| -7% | -$101K |
|
55
Vanguard Long-Term Corporate Bond ETF
VCLT
$6.71B
| $1.34M | 0.35% |
15,672
+677
| +5% | +$57.8K |
|
56
Bank of America
BAC
$371B
| $1.34M | 0.35% |
78,508
+2,386
| +3% | +$40.6K |
|
57
Deere & Co
DE
$127B
| $1.33M | 0.35% |
13,682
+95
| +0.7% | +$9.22K |
|
|
58
Ionis Pharmaceuticals
IONS
$9.64B
| $1.32M | 0.35% |
+22,859
| New | +$1.32M |
|
59
Toyota
TM
$252B
| $1.26M | 0.33% |
9,437
+1,145
| +14% | +$153K |
|
60
Citigroup
C
$175B
| $1.22M | 0.32% |
22,076
+2,132
| +11% | +$118K |
|
61
TJX Companies
TJX
$155B
| $1.18M | 0.31% |
35,700
-240
| -0.7% | -$7.94K |
|
62
PepsiCo
PEP
$203B
| $1.07M | 0.28% |
11,501
-2,447
| -18% | -$229K |
|
63
Berkshire Hathaway Class B
BRK.B
$1.08T
| $1.06M | 0.28% |
7,761
+519
| +7% | +$70.6K |
|
64
GSK
GSK
$79.3B
| $1.05M | 0.28% |
20,160
+1,066
| +6% | +$55.5K |
|
65
Altria Group
MO
$112B
| $1.04M | 0.27% |
21,274
-1,137
| -5% | -$55.6K |
|
66
Amazon
AMZN
$2.41T
| $1.04M | 0.27% |
47,880
-4,800
| -9% | -$104K |
|
67
Comcast
CMCSA
$125B
| $1M | 0.26% |
33,394
-2,528
| -7% | -$76K |
|
68
Bristol-Myers Squibb
BMY
$96.7B
| $992K | 0.26% |
14,914
-588
| -4% | -$39.1K |
|
69
Alkermes
ALKS
$4.95B
| $972K | 0.26% |
+15,114
| New | +$972K |
|
70
CVS Health
CVS
$93B
| $958K | 0.25% |
9,137
-1,075
| -11% | -$113K |
|
71
Amgen
AMGN
$153B
| $950K | 0.25% |
6,187
-636
| -9% | -$97.7K |
|
72
AbbVie
ABBV
$374B
| $932K | 0.25% |
13,871
-52
| -0.4% | -$3.49K |
|
73
Meta Platforms (Facebook)
META
$1.85T
| $926K | 0.24% |
10,802
-424
| -4% | -$36.3K |
|
|
RDS.A
74
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $921K | 0.24% |
16,150
+1,194
| +8% | +$68.1K |
|
75
RTX Corp
RTX
$212B
| $920K | 0.24% |
13,181
+696
| +6% | +$48.6K |
|